Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...
Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: ...
Moderna, Inc. engages in the development of ... Chien in 2010 and is headquartered in Cambridge, MA.
The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats CAMBRIDGE, MA / ACCESS ...
Hosted on MSN1mon
Moderna extends gains as EU offers COVID vaccine contractFollowing four straight sessions of gains, Moderna (NASDAQ ... 17 European countries will have access to the Cambridge, MA-based biotech's messenger RNA-based shot for up to four years.
CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted ...
CAMBRIDGE, MA / ACCESS Newswire / February 25, 2025 / Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences: TD Cowen 45 th Annual Health ...
RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results